Literature DB >> 17725857

Effects of water-soluble low-molecular-weight beta-1, 3-D-glucan (branch beta-1, 6) isolated from Aureobasidium pullulans 1A1 strain black yeast on restraint stress in mice.

Yoshiyuki Kimura1, Maho Sumiyoshi, Takahiro Suzuki, Toshio Suzuki, Masahiro Sakanaka.   

Abstract

It is well known that different stress paradigms are able to rapidly induce corticosterone production and immune function through the activation of the hypothalamic-pituitary-adrenal axis. It has been reported that glucocorticoids suppress natural killer (NK) activity and interleukin (IL)-1 production and, on the other hand, that IL-1 and IL-6 stimulate the release of corticotrophin-releasing-hormone from the rat hypothalamus. Moreover, it has been reported that IL-12 plays a central role in the initiation of cell-mediated immunity, directly and via its induction of interferon (IFN)-gamma and activation of NK cells. In this study, we examined the effects of water-soluble low-molecular-weight beta-glucan isolated from Aureobasidium pullulans 1A1 strain on the corticosterone levels and immune function, such as NK activity and IL-6 and IL-12 production, using a restraint stress-induced mouse model. The water-soluble low-molecular-weight beta-glucan at a dose of 50 or 100 mg kg(-1) inhibited the increases in the blood corticosterone level and the reduction of NK activity induced by restraint stress. Furthermore, the water-soluble low-molecular-weight beta-glucan (100 mg kg(-1)) prevented the reduction of IL-6 and IL-12 production by splenocytes caused by restraint stress. These findings suggest that the inhibitory actions of water-soluble low-molecular-weight beta-glucan on the increase in corticosterone level and reduction of NK activity induced by restraint stress may be associated with the abrogation of the IL-6 and IL-12 reduction caused by the stress. Thus, water-soluble low-molecularweight beta-glucan may be an effective dietary supplement for the prevention of stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725857     DOI: 10.1211/jpp.59.8.0012

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Effects of naproxen on the hypobaric hypoxia-induced immune changes in male rats.

Authors:  Ananda Raj Goswami; Nilotpal Mandal; Goutam Dutta; Tusharkanti Ghosh
Journal:  Eur J Appl Physiol       Date:  2012-01-21       Impact factor: 3.078

2.  Characterization and enzymatic hydrolysis of hydrothermally treated β-1,3-1,6-glucan from Aureobasidium pullulans.

Authors:  Katsuki Hirabayashi; Nobuhiro Kondo; Sachio Hayashi
Journal:  World J Microbiol Biotechnol       Date:  2016-11-01       Impact factor: 3.312

3.  Structural characterisation and biological activities of a unique type beta-D-glucan obtained from Aureobasidium pullulans.

Authors:  Rui Tada; Asuka Tanioka; Haruyo Iwasawa; Kumi Hatashima; Yoshikazu Shoji; Ken-ichi Ishibashi; Yoshiyuki Adachi; Masatoshi Yamazaki; Kazufumi Tsubaki; Naohito Ohno
Journal:  Glycoconj J       Date:  2008-06-28       Impact factor: 2.916

4.  Immune enhancing effects of WB365, a novel combination of Ashwagandha (Withania somnifera) and Maitake (Grifola frondosa) extracts.

Authors:  Vaclav Vetvicka; Jana Vetvickova
Journal:  N Am J Med Sci       Date:  2011-07

5.  Anti-stress action of an orally-given combination of resveratrol, β-glucan, and vitamin C.

Authors:  Vaclav Vetvicka; Jana Vetvickova
Journal:  Molecules       Date:  2014-09-03       Impact factor: 4.411

Review 6.  Biological Activity of High-Purity β-1,3-1,6-Glucan Derived from the Black Yeast Aureobasidium pullulans: A Literature Review.

Authors:  Toshio Suzuki; Kisato Kusano; Nobuhiro Kondo; Kouji Nishikawa; Takao Kuge; Naohito Ohno
Journal:  Nutrients       Date:  2021-01-16       Impact factor: 5.717

7.  β-Glucan derived from Aureobasidium pullulans is effective for the prevention of influenza in mice.

Authors:  Daisuke Muramatsu; Atsushi Iwai; Shiho Aoki; Hirohumi Uchiyama; Koji Kawata; Yosuke Nakayama; Yasuhiro Nikawa; Kisato Kusano; Mitsuyasu Okabe; Tadaaki Miyazaki
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.